doi: 10.3345/kjp.2013.56.6.269.
Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
- PMID: 23807895
- PMCID: PMC3693047
- DOI: 10.3345/kjp.2013.56.6.269
Item in Clipboard
Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
Korean J Pediatr.
2013 Jun.
No abstract available
Retraction of
-
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.Korean J Pediatr. 2011 Jun;54(6):241-5. doi: 10.3345/kjp.2011.54.6.241. Epub 2011 Jun 30. Korean J Pediatr. 2011. Retraction in: Korean J Pediatr. 2013 Jun;56(6):269. doi: 10.3345/kjp.2013.56.6.269. PMID: 21949518 Free PMC article. Retracted.
Similar articles
-
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.Nat Commun. 2012;3:1292. doi: 10.1038/ncomms2295. Nat Commun. 2012. PMID: 23250422 Free PMC article.
-
Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.Pediatr Neurol. 2015 Mar;52(3):281-9. doi: 10.1016/j.pediatrneurol.2014.10.028. Epub 2014 Nov 20. Pediatr Neurol. 2015. PMID: 25591831 Review.
-
Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.J Child Neurol. 2014 Sep;29(9):NP54-7. doi: 10.1177/0883073813499969. Epub 2013 Sep 20. J Child Neurol. 2014. PMID: 24056156
-
Topical Use of Mammalian Target of Rapamycin (mTOR) Inhibitors in Tuberous Sclerosis Complex-A Comprehensive Review of the Literature.Pediatr Neurol. 2016 Aug;61:21-7. doi: 10.1016/j.pediatrneurol.2016.04.003. Epub 2016 Apr 13. Pediatr Neurol. 2016. PMID: 27222056 Review.
-
Tuberous sclerosis complex: Recent advances in manifestations and therapy.Int J Urol. 2017 Sep;24(9):681-691. doi: 10.1111/iju.13390. Epub 2017 Jul 1. Int J Urol. 2017. PMID: 28667702 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
